MicroPort CardioFlow Medtech (HKSE:02160) 3-Year Revenue Growth Rate : 44.20% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is MicroPort CardioFlow Medtech 3-Year Revenue Growth Rate?

MicroPort CardioFlow Medtech's Revenue per Share for the six months ended in Dec. 2023 was HK$0.07.

During the past 12 months, MicroPort CardioFlow Medtech's average Revenue per Share Growth Rate was 32.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 44.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 6 years, the highest 3-Year average Revenue per Share Growth Rate of MicroPort CardioFlow Medtech was 44.20% per year. The lowest was -81.60% per year. And the median was -18.70% per year.

Competitive Comparison of MicroPort CardioFlow Medtech's 3-Year Revenue Growth Rate

For the Medical Devices subindustry, MicroPort CardioFlow Medtech's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MicroPort CardioFlow Medtech's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort CardioFlow Medtech's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where MicroPort CardioFlow Medtech's 3-Year Revenue Growth Rate falls into.

MicroPort CardioFlow Medtech 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

MicroPort CardioFlow Medtech (HKSE:02160) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

MicroPort CardioFlow Medtech 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of MicroPort CardioFlow Medtech's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroPort CardioFlow Medtech (HKSE:02160) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort CardioFlow Medtech Corp (HKSE:02160) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

72X:Germany

Address

No. 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai, CHN, 201203

Website

https://www.cardioflowmedtech.com

MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of three products VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China.

Executives

China Renaissance Holdings Limited	2201 Interest of corporation controlled by you
Hua Jie Tian Jin Yi Liao Tou Zi He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Shang Hai Hua Hao Qi Ye Guan Li He Huo Qi Ye You Xian He Huo	2101 Beneficial owner
Tian Jin Hua Jie Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Tian Jin Hua Qing Qi Ye Guan Li Zi Xun You Xian Gong Si	2201 Interest of corporation controlled by you
Microport Scientific Corporation	2201 Interest of corporation controlled by you
Shanghai Microport Limited	2101 Beneficial owner
China International Capital Corporation Limited	2201 Interest of corporation controlled by you
Cicc Capital Management Co., Ltd.	2201 Interest of corporation controlled by you
Cicc Kangrui I (ningbo) Equity Investment Limited Partners (limited Partnership)	2101 Beneficial owner
Cicc Kangzhi (ningbo) Equity Investment Management Co., Ltd.	2201 Interest of corporation controlled by you

MicroPort CardioFlow Medtech (HKSE:02160) Headlines

No Headlines